HealthFinSMEsabout 1 hour ago
Microbiotica Raises 36 Million Pounds
1 min read
Microbiotica, a Cambridge biopharma firm, raised 36 million pounds in Series C financing led by British Business Bank. The company plans to advance its ulcerative colitis drug MB310 into Phase 2 clinical development following positive Phase 1b study results.
Level
Hype check
Tap to vote and see what everyone thinks.
